Literature DB >> 23205677

Characteristics of cerebral ischemia in major rat stroke models of middle cerebral artery ligation through craniectomy.

Alexey Shmonin1, Elena Melnikova, Michael Galagudza, Timur Vlasov.   

Abstract

BACKGROUND: The refinement of experimental stroke models is important for further development of neuroprotective interventions. AIMS AND/OR HYPOTHESIS: Our goal was to study the reproducibility of outcomes obtained in five rat models of middle cerebral artery (MCA) ligation in order to identify the optimal model for the preclinical studies.
METHODS: In Part 1 of the experiments, systolic blood flow velocity (sBFV) and cerebral area at risk (AR) were determined immediately after the onset of brain ischemia induced in different ways in Wistar rats. After that, another set of experiments was performed (Part 2 of the experiments), now aimed at the assessment of the delayed outcome of five different models of cerebral ischemia designated as Versions 1-5. The versions were: Version 1 - 40-minute left MCA (LMCA) occlusion with reperfusion; Version 2 - permanent LMCA ligation; Version 3 - permanent ligation of both LMCA and left common carotid artery (CCA); Version 4 - permanent LMCA and bilateral CCA (bCCA) ligation; Version 5 - permanent LMCA ligation and 40-minute bCCA occlusion. The infarct size (IS) was quantified using triphenyltetrazolium chloride staining. The severity of neurological deficit was assessed by the Garcia score. The extent of brain edema was determined by calculating the difference in volumes of affected and contralateral hemispheres.
RESULTS: Within a relatively big AR, Versions 1 and 2 resulted in a small IS [0·2 (0·0; 0·4)% and 0·3 (0·0; 0·7)%, respectively, P > 0·05]. Unlike that and comparable with AR, Version 3 resulted in a greater, albeit more variable IS [5·9 (2·1; 8·3)%, P < 0·0001 vs. Version 2]. Also comparable with AR, Versions 4 and 5 produced greatest values of IS [14·5 (11·4; 17·9)% and 11·3 (10·1; 14·2)%, respectively]; this parameter was most reproducible in Version 5. A significant decrease in neurological deficit score was found in Versions 4 and 5. Again, the reproducibility of the data on neurological outcome was higher in Version 5 versus Version 4.
CONCLUSIONS: Comparative analysis of several Versions of focal cerebral ischemia within a single study might be helpful in better understanding of the mechanisms underlying the development and aftermath of stroke. Permanent LMCA ligation plus transient bilateral CCA occlusion produced most consistent results and might be recommended for preclinical studies.
© 2012 The Authors. International Journal of Stroke © 2012 World Stroke Organization.

Entities:  

Keywords:  animal models; area at risk; collateral blood supply; focal cerebral ischemia; infarct size; middle cerebral artery

Mesh:

Substances:

Year:  2012        PMID: 23205677     DOI: 10.1111/j.1747-4949.2012.00947.x

Source DB:  PubMed          Journal:  Int J Stroke        ISSN: 1747-4930            Impact factor:   5.266


  5 in total

1.  Neurotherapeutic activity of the recombinant heat shock protein Hsp70 in a model of focal cerebral ischemia in rats.

Authors:  Maxim A Shevtsov; Boris P Nikolaev; Ludmila Y Yakovleva; Anatolii V Dobrodumov; Anastasiy S Dayneko; Alexey A Shmonin; Timur D Vlasov; Elena V Melnikova; Alexander D Vilisov; Irina V Guzhova; Alexander M Ischenko; Anastasiya L Mikhrina; Oleg V Galibin; Igor V Yakovenko; Boris A Margulis
Journal:  Drug Des Devel Ther       Date:  2014-05-28       Impact factor: 4.162

2.  Effect of combination therapy using hypothermia and granulocyte colony-stimulating factor in a rat transient middle cerebral artery occlusion model.

Authors:  Laya Ghahari; Manouchehr Safari; Mohamad Taghi Joghataei; Mehdi Mehdizadeh; Mansoureh Soleimani
Journal:  Iran Biomed J       Date:  2014

Review 3.  An Evidence-Based Review of Related Metabolites and Metabolic Network Research on Cerebral Ischemia.

Authors:  Mengting Liu; Liying Tang; Xin Liu; Jing Fang; Hao Zhan; Hongwei Wu; Hongjun Yang
Journal:  Oxid Med Cell Longev       Date:  2016-05-05       Impact factor: 6.543

4.  Biomarkers of lesion severity in a rodent model of nonarteritic anterior ischemic optic neuropathy (rNAION).

Authors:  Yan Guo; Zara Mehrabian; Mary A Johnson; Neil R Miller; Amanda D Henderson; John Hamlyn; Steven L Bernstein
Journal:  PLoS One       Date:  2021-03-25       Impact factor: 3.240

5.  Stroke neuroprotection: targeting mitochondria.

Authors:  Lora Talley Watts; Reginald Lloyd; Richard Justin Garling; Timothy Duong
Journal:  Brain Sci       Date:  2013-04-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.